Publication: The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study
7
Issued Date
2019-01-01
Resource Type
ISSN
22107711
22107703
22107703
Other identifier(s)
2-s2.0-85076892639
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Clinical Pharmacy. (2019)
Suggested Citation
Onuma Sattayalertyanyong, Premrutai Thitilertdecha, Chonticha Auesomwang The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study. International Journal of Clinical Pharmacy. (2019). doi:10.1007/s11096-019-00955-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/50966
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The inappropriate use of proton pump inhibitors during admission and after discharge: a prospective cross-sectional study
Other Contributor(s)
Abstract
© 2019, Springer Nature Switzerland AG. Background Proton pump inhibitors are often inappropriately prescribed during hospital admission and after discharge. The inappropriate prescription may be associated with increased and unnecessary healthcare costs. Objective To determine the prevalence of inappropriate prescription of proton pump inhibitors during hospital admission and after discharge at Thailand’s largest national tertiary referral center. Setting Medicine wards at Siriraj Hospital (Bangkok, Thailand) during September 2016 to September 2017. Method This prospective observational cross-sectional study in hospitalized patients who were prescribed, or who were already taking proton pump inhibitors. Medical records were reviewed to determine whether proton pump inhibitors were prescribed at discharge and at the 1-month follow-up. Main outcome measure Prevalence of inappropriate prescription of proton pump inhibitors during hospital admission and after discharge, indication of inappropriate prescription. Results Two hundred and sixty-five patients (mean age: 65.8 ± 18.3 years, 50.9% men) were included. Approximately half of patients had proton pump inhibitor treatment initiated in the hospital, and the other 50.6% started treatment earlier. Among all patients, 50.6% were inappropriately prescribed proton pump inhibitors, in which 79.1% resulted from invalid indications. Fifty-two percent and 47.3% of patients who were prescribed proton pump inhibitors at discharge and at the 1-month follow-up had no indications for them. Gastrointestinal ulcer prophylaxis in low-risk patients was the most commonly observed incorrect indication. Aspirin (p = 0.030) and corticosteroids (p = 0.038) were both found to be significantly associated with the inappropriate prescription of proton pump inhibitors. The estimated cost of inappropriate use among inpatients and outpatients was $118,659 and $214,663 per year, respectively. Conclusion Proton pump inhibitors are excessively and inappropriately prescribed during hospital admission and after discharge in Thailand. The cost of this overprescribing is excessive and needs to be controlled.